Unknown NA INTERVENTIONAL 2-arm NCT04647162

A Clinical Trial About the Safety of Surgical Treatment in Severe Primary Pontine Hemorrhage (STIPE)

Safety of Surgical Treatment In Severe Primary Pontine Hemorrhage Evacuation (STIPE): a Multicentric, Randomized, Controlled, Open-label Trial

Sponsor: West China Hospital

Conditions Cerebrovascular Disorders Pontine Hemorrhage Primary Surgery

Interventions hematoma evacuation by craniotomy hematoma evacuation by neuroendoscopy hematoma evacuation by stereotactic puncture life support

Updated 9 times since 2020 Last updated: Dec 6, 2023 Started: Jan 1, 2022 Primary completion: Nov 30, 2024 Completion: Nov 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cerebrovascular Disorders and Pontine Hemorrhage and is currently ongoing. West China Hospital leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA
Sep 2022 — Jan 2024 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Jan 2022 — Sep 2022 [monthly]

Recruiting NA
May 2021 — Jan 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — May 2021 [monthly]

Not Yet Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

West China Hospital

Data source: West China Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baoji, China , Beijing, China , Chengdu, China , Fuzhou, China , Gaozhou, China , Guangzhou, China , Hangzhou, China , Harbin, China , Hefei, China , Mianyang, China and 7 more locations